SBX:XETRA SynBiotic SE

EUR 12.90 0.20 1.574803
Icon

SynBiotic SE (SBX:XETRA) Stock Analysis and Price Targets

COMMON STOCK | Drug Manufacturers - Specialty & Generic | XETRA
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 12.90

+0.20 (+1.57)%

EUR 0.05B

0.02M

N/A

N/A

Icon

SBX:XETRA

SynBiotic SE (EUR)
COMMON STOCK | XETRA
EUR 12.90
0.00 0
Take a Tour
stockTargetAdvisor

N/A

Average Analyst
Rating
stockTargetAdvisor

N/A

Top Analyst
Rating
stockTargetAdvisor

Bearish

Stock Target Advisor
Analysis
stockTargetAdvisor

N/A

Average User
Rating

EUR 0.05B

N/A

EUR 12.90

SynBiotic SE (SBX:XETRA) Stock Forecast

N/A

Based on the SynBiotic SE stock forecast from 0 analysts, the average analyst target price for SynBiotic SE is not available over the next 12 months. SynBiotic SE’s average analyst rating is not available. Stock Target Advisor’s own stock analysis of SynBiotic SE is Bearish, which is based on 1 positive signals and 6 negative signals. At the last closing, SynBiotic SE’s stock price was EUR 12.90. SynBiotic SE’s stock price has changed by +8.86% over the past week, +42.70% over the past month and +42.38% over the last year.

No recent analyst target price found for SynBiotic SE
No recent average analyst rating found for SynBiotic SE

Company Overview SynBiotic SE

SynBiotic SE engages in the research and development, production, and marketing of cannabinoid and terpene-based solutions to for pain, sleep deprivation, and anxiety. It also offers hemp, cannabinoids, dietary supplements, and cosmetic products; medical cannabis products; and ca...Read More

https://www.synbiotic.com

Barer Strasse 7, Munich, Germany, 80333

104

December

EUR

Germany

Adjusted Closing Price for SynBiotic SE (SBX:XETRA)

Loading...

Unadjusted Closing Price for SynBiotic SE (SBX:XETRA)

Loading...

Share Trading Volume for SynBiotic SE Shares

Loading...

Compare Performance of SynBiotic SE Shares

Symbol Capital Gain Dividend Return Total Return
Loading...
Loading...

Technical Indicators for SBX:XETRA

Assets

Top Holdings

Top Sectors

Top Regions

Stocks Similar To SynBiotic SE (Sector: Drug Manufacturers - Specialty & Generic )

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
ZOE:XETRA
Zoetis Inc +3.25 (+2.09%) EUR75.55B 35.48 21.98

ETFs Containing SBX

Symbol Name SBX's Weight Expense Ratio Price(Change) Market Cap
no data

Frequently Asked Questions About SynBiotic SE (SBX:XETRA) Stock

Stock Target Advisor's fundamental analysis for SynBiotic SE's stock is Bearish.

Unfortunately we do not have enough data on SBX:XETRA's stock to indicate if its a good dividend stock.

Unfortunately we do not have enough data on SBX:XETRA's stock to indicate what its average analyst target is.

Unfortunately we do not have enough data on SBX:XETRA's stock to indicate if its overvalued.

The last closing price of SBX:XETRA's stock was EUR 12.90.

The most recent market capitalization for SBX:XETRA is EUR 0.05B.

Unfortunately we do not have enough analyst data on SBX:XETRA's stock to indicate whether its price will go up or not.

We can't find any ETFs which contains SynBiotic SE's stock.

As per our most recent records SynBiotic SE has 104 Employees.

SynBiotic SE's registered address is Barer Strasse 7, Munich, Germany, 80333. You can get more information about it from SynBiotic SE's website at https://www.synbiotic.com.
Heading 1 Heading 2 Heading 3 Heading 4 Heading 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5
Data 1Data 2Data 3Data 4Data 5

Stock Target Advisor's Analysis

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

Icon
What to like

Icon
What not to like

Loading...